James V Caruso insider trades: Cellectar Biosciences (CLRB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | CLRB | ↑ Buy | 8,680 | $2.88 | $25K | Direct | May 11, 2026 (4d) |
| Jul 2, 2025 | CLRB | ↑ Buy | 10,000 | $4.99 | $50K | Direct | Jul 3, 2025 (1d) |
| Mar 4, 2021 | CLRB | ↑ Buy | 5,100 | $1.70 | $9K | Direct | Mar 5, 2021 (1d) |
| Dec 28, 2020 | CLRB | ↑ Buy | 37,037 | $1.35 | $50K | Direct | Dec 28, 2020 (0d) |
| Jun 5, 2020 | CLRB | ↑ Buy | 21,740 | $1.15 | $25K | Direct | Jun 8, 2020 (3d) |
| Nov 30, 2018 | CLRB | ↑ Buy | 1,000 | $2.28 | $2K | Direct | Nov 30, 2018 (0d) |
| Mar 12, 2018 | CLRB | ↓ Sell | 34,000 | $1.20 | $41K | Direct | Mar 14, 2018 (2d) |
| Apr 20, 2016 | CLRB | ↑ Buy | 46,948 | $2.12 | $100K | Direct | Apr 21, 2016 (1d) |
| Nov 24, 2015 | CLRB | ↑ Buy | 1,000 | $1.30 | $1K | Direct | Nov 25, 2015 (1d) |
| Nov 20, 2015 | CLRB | ↑ Buy | 1,000 | $1.16 | $1K | Direct | Nov 24, 2015 (4d) |
| Nov 19, 2015 | CLRB | ↑ Buy | 4,000 | $1.45 | $6K | Direct | Nov 19, 2015 (0d) |
| Mar 1, 2010 | ALTH | ↓ Sell10b5-1 | 77,500 | $8.13 | $630K | Direct | Mar 3, 2010 (2d) |
| Feb 23, 2010 | ALTH | ↓ Sell10b5-1 | 5,968 | $7.44 | $44K | Direct | Feb 24, 2010 (1d) |
| Aug 10, 2009 | ALTH | ↓ Sell10b5-1 | 85,400 | $8.13 | $694K | Direct | Aug 12, 2009 (2d) |
| Aug 5, 2009 | ALTH | ↓ Sell10b5-1 | 64,600 | $7.87 | $508K | Direct | Aug 5, 2009 (0d) |
| Jun 16, 2009 | ALTH | ↓ Sell10b5-1 | 27,500 | $8.14 | $224K | Direct | Jun 17, 2009 (1d) |
| Mar 26, 2009 | ALTH | ↓ Sell10b5-1 | 46,400 | $7.34 | $340K | Direct | Mar 27, 2009 (1d) |
| Mar 16, 2009 | ALTH | ↓ Sell10b5-1 | 53,600 | $7.13 | $382K | Direct | Mar 16, 2009 (0d) |
| Sep 2, 2008 | ALTH | ↓ Sell10b5-1 | 10,000 | $9.68 | $97K | Direct | Sep 3, 2008 (1d) |
| Jun 6, 2007 | ALTH | ↓ Sell10b5-1 | 10,000 | $5.61 | $56K | Direct | Jun 8, 2007 (2d) |
| Dec 29, 2006 | ALTH | ↑ Buy | 2,500 | $3.05 | $8K | Direct | Jan 3, 2007 (5d) |
| May 4, 2005 | BCII | ↓ Sell | 30,000 | $32.13 | $964K | Direct | May 5, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLRB insiders
Open-market trades in the last 12 months
About James V Caruso's insider trades
James V Caruso is President & CEO at Cellectar Biosciences (CLRB). Since May 4, 2005, James has reported 11 open-market purchases worth $276K and 11 sales worth $4.0M on SEC Form 4. In the last 12 months: 1 buy ($25K).
9 sales (75% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (17 filings), option exercises (6 filings), other transactions (5 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.